Pharmacy Benefit Management

From Radar on Drug Benefits - Despite pharmaceutical manufacturer drug price increases of nearly 10%, CVS Health Corp’s PBM Caremark reported nearly flat year-over-year drug price growth at 0.2%. Overall, 42% of payer clients spent less on their pharmacy benefit plan in 2017 than they had spent in 2016. According to the company’s annual drug trend report, in 2017, its PBM strategies reduced the drug trend for commercial clients to 1.9% per member per year: 0.2% drug price growth plus 1.7% utilization growth. Read more

From Radar on Drug Benefits - The Pharmaceutical Research and Manufacturers of America (PhRMA)’s recent ad campaign takes aim at so-called copay accumulator programs, whereas America’s Health Insurance Plans (AHIP) contends that drug manufacturers’ copay coupons are the bigger problem. Under copay accumulator programs, payers prevent the dollar value of manufacturers’ coupons from applying to patients’ deductibles, instead only counting payments made by the members themselves. Read more

It's quick and easy to sign up for FREE access to!

Why do I need to register?

Resources for Paid Subscribers
Not a Paid Subscriber?

Check out all of the benefits, sample issues & more!